Alopecia areata during anti-TNF alpha therapy: Nine cases;Pelade au cours d'un traitement par anti-TNF alpha: neuf cas

Annales de Dermatologie et de Venereologie

Volumn 138, Issue 4, 2011, Pages 285-293

  Le Bidre, E ^a   Chaby, G ^b   Martin, L ^c   Perrussel, M ^d   Sassolas, B ^e   Sigal, M L ^f   Kaassis, C ^g   Lespessailles, E ^a   Nseir, A ^a   Estve, E ^a  

^a CENTRE HOSPITALIER RÉGIONAL D ORLÉANS   (France)

^b AMIENS UNIVERSITY HOSPITAL   (France)

^c ANGERS UNIVERSITY HOSPITAL   (France)

^d Cabinet de Dermatologie de Limeil Brevannes   (France)

^e BREST UNIVERSITY HOSPITAL   (France)

^f CHR d'Argenteuil   (France)

^g Cabinet de Dermatologie   (France)

Author keywords

Adalimumab; Alopecia areata; Anti TNF alpha; Etanercept; Side effect

Indexed keywords

ADALIMUMAB; CORTICOSTEROID; ETANERCEPT; METHOTREXATE;

ADULT; ALOPECIA AREATA; ARTICLE; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DISEASE COURSE; DRUG WITHDRAWAL; FEMALE; HAIR GROWTH; HUMAN; MALE; MEDICAL HISTORY; TREATMENT RESPONSE;

ADULT; ALOPECIA; ALOPECIA AREATA; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; RISK FACTORS; STRESS, PSYCHOLOGICAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79954628956     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annder.2011.01.047     Document Type: Article

References (24)

1. N. Bonnet, S. Guis, M.C. Koeppel, J. Roudier, J.C. Grimaud, and M.J. Jean-Pastor Evénements cutanéomuqueux au cours des traitements par anti-TNF alpha: étude observationnelle prospective de 41 cas Ann Dermatol Venereol 137 2010 12 20
2. Y. Chaves, G. Duarte, B. Ben-Said, J. Tebib, F. Berard, and J.F. Nicolas Alopecia areata universalis during treatment of rheumatoid arthritis with anti-TNF-alpha antibody (adalimumab) Dermatology 217 2008 380
3. N. Garcia Bartels, H.H. Lee, M. Worm, G.R. Burmester, W. Sterry, and U. Blume-Peytavi Development of alopecia areata universalis in a patient receiving adalimumab Arch Dermatol 142 2006 1654 1655 (Pubitemid 44969233)
4. N. Pelivani, A.S. Hassan, L.R. Braathen, R.E. Hunger, and N. Yawalkar Alopecia areata universalis elicited during treatment with adalimumab Dermatology 216 2008 320 323 (Pubitemid 351630097)
5. C. Kirshen, and N. Kanigsberg Alopecia areata following adalimumab J Cutan Med Surg 13 2009 48 50
6. C. Fabre, and O. Dereure Worsening alopecia areata and de novo occurrence of multiple halo nevi in a patient receiving infliximab Dermatology 216 2008 185 186 (Pubitemid 351158591)
7. L. Ettefagh, S. Nedorost, and P. Mirmirani Alopecia areata in a patient using infliximab: new insights into the role of tumor necrosis factor on human hair follicles Arch Dermatol 140 2004 1012 (Pubitemid 39062659)
8. A. Tosti, M. Pazzaglia, M. Starace, S. Bellavista, C. Vincenzi, and G. Tonelli Alopecia areata during treatment with biologic agents Arch Dermatol 142 2006 1653 1654 (Pubitemid 44969232)
9. M.V. Hernández, S. Nogués, V. Ruiz-Esquide, M. Alsina, J.D. Cañete, and R. Sanmartí Development of alopecia areata after biological therapy with TNF-alpha Blockers: description of a case and review of the literature Clin Exp Rheumatol 27 2009 892 893
10. Y. Pan, and N.A. Rao Alopecia areta during étanercept theraphy Ocul Immunol Inflamm 17 2009 127 129
11. W. Posten, and J. Swan Recurrence of alopecia areata in a patient receiving etanercept injections Arch Dermatol 141 2005 759 760 (Pubitemid 41001077)
12. A.C. Katoulis, A. Alevizou, E. Bozi, S. Georgala, M. Mistidou, and D. Kalogeromitros Biologic agents and alopecia areata Dermatology 218 2009 184 185
13. D. Nakagomi, K. Harada, A. Yagasaki, T. Kawamura, N. Shibagaki, and S. Shimada Psoriasiform eruption associated with alopecia areata during infliximab therapy Clin Exp Dermatol 34 2009 923 924
14. Ferran M, Calvet J, Almirall M, Pujol RM, Maymó J. Alopecia areata as another immune-mediated disease developed in patients treated with tumour necrosis factor-alpha blocker agents. J Eur Acad Dermatol Venereol 2011;25:479-84, doi:10.1111/j.1468-3083.2010.03770.x.
15. M. Viguier, P. Richette, H. Bachelez, D. Wendling, and F. Aubin Manifestations cutanées paradoxales des anti-TNF-alpha Ann Dermatol Venereol 137 2010 64 71
16. S.A. Exarchou, P.V. Voulgari, T.E. Markatseli, A. Zioga, and A.A. Drosos Immune-mediated skin lesions in patients treated with anti-tumour necrosis factor alpha inhibitors Scand J Rheumatol 38 2009 328 331
17. E. Tan, Y.K. Tay, C.L. Goh, and Y. Chin Giam The pattern and profile of alopecia areata in Singapore- a study of 219 Asians Int J Dermatol 41 2002 748 753 (Pubitemid 35422838)
18. K.H. Safavi, S.A. Muller, V.J. Suman, A.N. Moshell, and L.J. 3rd Melton Incidence of alopecia areata in Olmsted County Minnesota, 1975 through 1989 Mayo Clin Proc 70 1995 628 633
19. M.P. Philpott, D.A. Sanders, J. Bowen, and T. Kealey Effects of interleukins, colony-stimulating factor and tumour necrosis factor on human hair follicle growth in vitro: a possible role for interleukin-1 and tumour necrosis factor-alpha in alopecia areata Br J Dermatol 135 1996 942 948 (Pubitemid 26397924)
20. S. Gregoriou, D. Papafragkaki, G. Kontochristopoulos, E. Rallis, D. Kalogeromitros, and D. Rigopoulos Cytokines and other mediators in alopecia areata Mediators Inflamm 2010 2010 928030
21. W. Abramovits, and M. Losornio Failure of two TNF-alpha blockers to influence the course of alopecia areata Skinmed 5 2006 177 181
22. K.J. McElwee, P. Freyschmidt-Paul, J.P. Sundberg, and R. Hoffmann The pathogenesis of alopecia areata in rodent models J Investig Dermatol Symp Proc 8 2003 6 11 (Pubitemid 36900483)
23. R.S. Kalish, and A. Gilhar Alopecia areata: autoimmunity-the evidence is compelling J Investig Dermatol Symp Proc 8 2003 164 167 (Pubitemid 37222823)
24. A. Gilhar, R. Shalaginov, B. Assy, S. Serafimovich, and R.S. Kalish Alopecia areata is a T-lymphocyte mediated autoimmune disease: lesional human T-lymphocytes transfer alopecia areata to human skin grafts on SCID mice J Investig Dermatol Symp Proc 4 1999 207 210 (Pubitemid 30085805)